Cambrian Bioworks

Advancing diagnostics

Bengaluru, India · Founded 2020 · $1.4M raised

Headquarters
Bengaluru
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$1.4M
Last Round
$1.4M SeedAug 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cambrian Bioworks is a Bengaluru-based biotech company developing automated solutions for genomic testing and molecular diagnostics. Founded in 2020, the company designs and manufactures instruments and kits for DNA/RNA extraction, nucleic acid quantification, and amplification workflows used in clinical and research laboratories. Its flagship products — the Manta and Beluga platforms — automate sample-to-result molecular workflows, enabling labs ranging from small research teams to high-throughput diagnostic centers to achieve fast, reliable, and reproducible results in cancer genomics, infectious disease detection, and personalized medicine.

Summary

Cambrian Bioworks is a Biotech company based in Bengaluru, India, founded in 2020. It has raised $1.4M in total across 1 round, most recently a $1.4M Seed round in Aug 2024. Investors include Irani Family Office.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundAug 2024
$1.4M

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cambrian Bioworks on Indexed.vc
<a href="https://indexed.vc/companies/cambrian-bioworks"><img src="https://indexed.vc/api/badge/company/cambrian-bioworks" alt="Cambrian Bioworks on Indexed.vc" width="260" height="76" /></a>